INTRODUCTION
In the 1960s, when silicone breast implants began to be used in breast augmentation
surgery, the histopathological and immunohistochemical evaluation of the capsule formed
around the implants was performed only for research purposes, to study the body’s
reaction to different types of envelopes and, eventually, detect silicone leakage.
Recently, with the increase in patients requesting implant removal due to different
clinical complaints and the concern for the diagnosis of breast implant-associated
anaplastic T-cell lymphoma (BI-ALCL), which is usually located in the peri-implant
fibrous capsule region, the shipment of specimens for anatomopathological examination
has increased1.
The diagnosis of the pathophysiological changes that may occur around the implants
is essentially based on the change in the patient’s clinical status and imaging tests.
However, it is the association of histology results and the immunohistochemical profile
of the lesion that determine the diagnosis2,3.
The quality of the histopathological report depends on the precise execution of the
multiple steps of this examination, from the surgeon’s sampling to the histopathological
interpretation of the image. One of the steps in this process is the correlation with
the patient’s clinical and surgical data. These data should be obtained by accessing
the patient’s chart and requesting the surgeon in charge. However, access to patient
clinical, surgical and laboratory data by the pathologist is not always easy; the
specialized pathology service is not always part of the hospital complex where the
patient was operated on, making access to medical records difficult. The surgery may
have been performed in another hospital with a different chart or in another city.
The examination request by the surgeon represents a consultation request, and communication
between the surgeon and the pathologist is an essential step in the diagnosis. The
content of this request made by the surgeon must provide as much information as possible
associated with the histopathological and histochemical findings, allowing the pathologist
to prepare the report accurately. Errors and discrepancies in the pathological report
may occur due to insufficient clinical information4,5.
OBJECTIVE
This study aims to evaluate the quantity and quality of data provided by the surgeon
when requesting histopathological examination in patients undergoing definitive removal
surgery or exchange of gelatinous silicone breast implants.
METHODS
From December 15, 2018, to April 30, 2020, 3,043 consecutive medical requests were
studied for the histopathological study of samples obtained from breast surgeries
performed in surgical centers of six hospitals and in the invasive radiology service
that were sent to the service of clinical pathology, all members of Rede D’Or São
Luiz.
The data contained in the institution’s standardized anatomopathological examination
request form, which the requesting physician must complete, were recorded, including
gender, age, laterality, location in the breast, type of surgery, specimen description,
number of sample recipients sent, history clinic, signs and symptoms and diagnostic
hypothesis.
It was also noted whether there were data on the previous radiotherapy, previous chemotherapy,
type of breast implant removed, previous surgeries and previous imaging exams with
the BI-RADS classification (Breast Imaging Data Reporting System). Finally, the specialty
of the requesting physician was noted. The specialties of gynecology and mastology
were grouped as gynecology.
The surgeries performed were classified into five categories of indications: breast
cancer, benign breast pathologies, gynecomastia, breast reduction and need for removal
or replacement of breast implants.
The research project was submitted to the Research Ethics Committee of Rede D’Or São
Luiz under registration CAAE 05678918.1.0000.0087.
RESULTS
All 3043 studied cases were included. Surgeries involving the removal or replacement
of implants totaled 251 (8.24%), 250 replacements and one explant (Table 1). The mean age of patients was 43 years; laterality was not mentioned in 16 requests
(0.84%). The anatomical and spatial location was noted in 15 cases (6.33%). The type
of surgery performed was mentioned in 40 (15.94%). Previous imaging examination was
reported in one case (Table 2).
Table 1 - Description of medical indications for breast surgery.
Indications for surgeries |
Number of requests |
Values in Percentage of Total |
Neoplasms (including ultrasound-guided biopsies) |
1,444 |
47.45% |
Reducing mammoplasty |
586 |
19.25% |
Benign breast diseases |
583 |
19.15% |
Removal and/or replacement of silicone breast implants |
251 |
8.24% |
Gynecomastia |
179 |
5.88% |
Total |
3043 |
100% |
Table 1 - Description of medical indications for breast surgery.
Table 2 - Information contained in the anatomopathological examination request.
Information contained in the request |
Number |
Percentage |
Laterality |
235 |
99.16% |
Anatomical and/or spatial location |
15 |
6.33% |
BIRADS |
1 |
0.40% |
Clinical history |
48 |
19.12% |
Signals and symptoms |
35 |
13.94% |
Prior imaging exam |
12 |
4.78% |
Radiotherapy |
1 |
0.40% |
Chemotherapy |
0 |
0.00% |
Dimensions |
1 |
0.40% |
Diagnostic hypothesis |
131 |
55.27% |
Type of surgery performed |
40 |
15.94% |
Type of Implant removed |
0 |
0.00% |
Presence of liquid collection |
15 |
6.33% |
Table 2 - Information contained in the anatomopathological examination request.
Clinical history data were missing in 48 (19.12%), and signs and symptoms in 35 (13.94%).
In 15 requests, there was a reference to the current presence of fluid around the
implant, referred to in all of them with the term “chronic seroma” (Table 2). The clinical hypothesis was present in 131 requests, and in 64, there was only
the word contracture. And in 15, the term rupture. The requests mentioned the clinical
hypothesis of lymphoma on 27 occasions; 20 wrote the term BI-ALCL, and the other seven
lymphomas. Forty requests included the surgery that was performed (Table 3).
Table 3 - Diagnostic hypothesis inserted by the surgeon in the anatomopathological examination
request.
Diagnostic hypothesis |
Number of cases |
Contracture |
64 |
Break |
15 |
Infection |
5 |
Malignant neoplasm |
16 |
BI-ALCL* |
21 |
BI-ALCL* with seroma present
|
6 |
Late seroma |
3 |
Organized hematoma |
1 |
Total with hypothesis inserted |
131 |
Total requisitions |
151 |
Table 3 - Diagnostic hypothesis inserted by the surgeon in the anatomopathological examination
request.
The number of containers sent ranged from 1 to 5, with a median of 2. Of the 251 cases,
242 sent the capsule, 161 sent only the capsule, 27 contained capsule and breast tissue
in the same container without mentioning whether they were connected or separated,
and, in 54 patients, capsules and breast tissue from the same breast were shipped
in different containers. In 17 patients, an immunohistochemical study of CD30 was
requested for the tissue sent. In nine cases, fluid was collected and sent for examination
representing a specimen (Table 4).
Table 4 - Type of material shipped in containers.
Type of material sent (per specimen) |
Number |
Capsule only |
161 |
Only breast tissue |
9 |
Breast + capsule in the same container |
27 |
Breast and capsule in separate containers |
54 |
Nodule |
16 |
Liquid = seroma |
9 |
Table 4 - Type of material shipped in containers.
None of the requests contained data on the type of implant, brand, anatomical location
concerning the pectoralis major muscle, and the length of stay of the implants.
The 251 patients underwent surgery by 57 requesting physicians, 29 of whom were certified
plastic surgeons, five gynecologists, three anesthesiologists, and 20 physicians with
no defined specialty (Table 5).
Table 5 - Specialty of the referring physician.
Medical specialty |
Total of 57 different |
Plastic surgery |
29 |
Gynecology |
5 |
Anesthetist |
3 |
No specialty |
20 |
Table 5 - Specialty of the referring physician.
DISCUSSION
The description, in 1997, of the BI-ALCL resulted in changes in the conduct of the
removal of silicone breast implants6. The concepts of removing periprosthetic tissues have been discussed, whether en
bloc together with the capsule or limited to total or partial capsulectomy. Histopathological
examination, considered non-essential in most cases7-9, has become indispensable on many occasions. The importance of exchanging information
between the surgeon in charge and the physicians involved in the diagnosis, especially
radiologists and pathologists10, has also increased.
Another recent change factor is the surgery of definitive removal of the implants
by demand of the patient, labeled as explant surgery, which brings with it the concept
of the complete removal of the capsule that involves the implant. Studies have been
carried out to evaluate the histological alterations in these cases to find evident
correlations between the histological and histochemical findings and the diseases
reported by the patients, making it essential to pay greater attention to the evaluation
of the removed tissues11-13.
The lack of quantity and quality of the information in the medical request forms can
compromise the quality of the surgical pathology report and, consequently, the definitive
diagnosis. It should be noted that in this study, no request contained information
about the type and brand of the implant, even though the relationship between a particular
manufacturer and the high-texture envelopes with BI-ALCL14 was recognized.
Of the 251 requests, only two indicated the anatomical and spatial location of the
submitted specimens. In cases with suspected tumors, the need to determine an exact
location is well-defined15. However, it is also essential when the implant rupture, as the leaked material can
infiltrate adjacent tissues and cause acute and long-term inflammatory reactions.
Surgical samples should be demarcated to allow for their anatomical and spatial location.
With this simple practice, it would be possible to determine the region of the affected
breast, facilitating surveillance and interpretation in future examinations. It would
also make it possible to guide the exact location for any surgical revisions, particularly
when other tissues are involved, such as muscles or ribs.
Grubstein et al.16 warned about the difficulty of differentiating, in imaging diagnosis, siliconoma
from other conditions, especially breast cancer. Incorrect diagnosis leads to unnecessary
examinations and interventions. The same happens when implants with an external envelope
covered with polyurethane are used, which presents gradual degradation of this material
and the presence of a chronic inflammatory reaction. When it is necessary to remove
them, the capsule and the adjacent tissue must be resected, as the presence of residual
fragments can result in the formation of nodules and lead to a new surgical revision17. Therefore, the tissue sent must be very well-identified regarding the spatial position
and the relationship between the tissue fragments removed, even more so if sent in
more than one container.
In the present study, in 242 cases, the capsule was sent for anatomopathological examination,
in 161 in isolation and in 54, the breast tissue was also removed but sent in separate
containers. This may have occurred due to the surgical technique and the need to correct
the contour of the breast tissue associated with the replacement of implants, but
the surgeon should inform this fact. However, only 15.40% (40) of the requests contained
information about the surgical technique performed.
This finding indicates, as already warned by Lapid et al.8 in 2014, the need to create a protocol to standardize the surgical removal of the
capsule and the adjacent breast tissue, preferably en bloc, even in purely aesthetic
breast procedures.
In some cases, even when the implant appears to be visually intact, gel leakage may
occur17. In these cases, during the surgical procedure to remove the implant, changes in
the appearance of the implant may be detected, or a loss in the measured weight of
the implant may also occur. This information could be present in medical requests.
Of the 27 cases in which a diagnostic evaluation for BI-ALCL was requested, in 15,
the presence of fluid around an implant was reported. In nine of them, the liquid
was sent simultaneously with the other specimens. Reports show that 100% of cases
diagnosed with BI-ALCL present chronic fluid collection around the implant, and prior
needle aspiration guided by ultrasound examination is recommended for material collection
and cytology and immunohistochemical studies for research of CD 30 to ALK in order
to determine clinical and surgical management18,19.
The data obtained in this study suggest that the surgeons failed to provide information
in the request about the existence of some previous imaging exams followed by a puncture.
It is also possible to infer that the clinical history researched may have been insufficient.
It should be noted that not performing aspiration prior to surgery is not following
current protocols3,19.
Information on clinical history was present in 34.52% of the 3043 requests for breast
surgeries; however, in cases of implant removal, the rate was significantly lower,
only 19.12%. The diagnostic hypothesis, an item contained in the exam requisition
form, was only completed in 131 (52.19%), and in 64, only the mention of contracture,
which is a physical sign or a finding on physical examination, which can be accompanied
by other signs or symptoms such as pain.
This conceptual error seems to indicate, for the pathologist, that the understanding
by plastic surgeons of the possible causes of contracture and the clinical evolution
of this process is insufficient. The search for causal factors of contracture follows
a line of reasoning that should be transmitted to the pathologist synthetically and
objectively.
The lack of information in the medical request and, in particular, the lack of mention
of laterality in 16 cases makes direct communication between the pathologist and the
surgeon necessary, which results in a demand for time and cost for the laboratory.
This can delay the definition of the diagnosis and the issuance of reports4,5,20.
When reviewing articles that discuss errors and discrepancies in surgical pathology,
this lack of communication was not pointed out as a significant factor compared to
all the failures detected in the steps of the histopathological examination. The interpretation
of findings in the histopathological and histochemical examination has progressed
a lot due to the increasing specialization of pathologists and the change in the work
environment, composed of more specialized and larger teams, with the possibility of
personal exchange of information or employing information technology.
However, the lack of completed data found in this research demonstrates that when
a new clinical condition arises, as with BI-ALCL or explant surgery, a new process
of adaptation and medical education is necessary for all specialists involved. . The
information deficit in the medical request could be improved through the implementation
of protocols and information technology to communicate the surgeon to the pathologist
better.
CONCLUSIONS
Our results demonstrate that the quantity and quality of information contained in
the medical request are scarce, which could compromise the pathological report. Most
requesting physicians were certified plastic surgeons, and plastic surgery societies
have gone to great lengths to report and clarify the recent adverse effects of silicone
breast implants, especially regarding BI-ALCL or explant surgery. However, our findings
suggest that these mechanisms still need improvement. Surgeons and pathologists should
be encouraged to create means of communication through protocols and the use of information
technology.
REFERENCES
1. Miranda RN, Feldman AL, Soares FA. Breast implant-associated anaplastic large cell
lymphoma. In: Allison KH, ed. World Health Organization breast tumours. Lyon: IARC;
2019. p. 245-8.
2. Kim B, Predmore ZS, Mattke S, van Busum K, Gidengil CA. Breast Implant-associated
Anaplastic Large Cell Lymphoma: Updated Results from a Structured Expert Consultation
Process. Plast Reconstr Surg Glob Open. 2015;3(1):e296.
3. Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN Consensus Guidelines on the Diagnosis
and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Aesthet Surg J. 2019;39(Suppl_1):S3-13.
4. Nakhleh RE, Gephardt G, Zarbo RJ. Necessity of clinical information in surgical pathology.
Arch Pathol Lab Med. 1999;123(7):615-9.
5. Burton JL, Stephenson TJ. Are clinicians failing to supply adequate information when
requesting a histopathological investigation? J Clin Pathol. 2001;54(10):806-8.
6. Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline- filled
breast implant. Plast Reconstr Surg. 1997;100(2):554-5.
7. Roth FS, Felder JM, Friedman JD. Friedman JD. Breast capsulectomy specimens and their
clinical implications. Plast Reconstr Surg. 2010;126(6):1848-52.
8. Lapid O, Noels EC, Meijer SL. Pathologic Findings in Primary Capsulectomy Specimens:
Analysis of 2531 Patients. Aesthet Surg J. 2014;34(5):714-8.
9. Fisher M, Alba B, Bhuiya T, Kasabian AK, Thorne CH, Tanna N. Routine Pathologic Evaluation
of Plastic Surgery Specimens: Are We Wasting Time and Money? Plast Reconstr Surg.
2018;141(3):812-6.
10. Anger J, Elias PE, Moraes PC, Hamerschlak N. A review of data in medical request and
the patient questionnaire for magnetic resonance evaluation of silicone breast implants.
Einstein (Sao Paulo). 2017;15(4):465-9.
11. Rohrich RJ, Kaplan J, Dayan E. Silicone Implant Illness: Science versus Myth? Plast
Reconstr Surg. 2019;144(1):98-109.
12. de Boer M, Colaris M, van der Hulst RRWJ, Cohen Tervaert JW. Is explantation of silicone
breast implants useful in patients with complaints? Immunol Res. 2017;65(1):25-36.
13. Kaplan J, Rohrich R. Breast implant illness: a topic in review. Gland Surg. 2021;10(1):430-43.
14. Loch-Wilkinson A, Beath KJ, Knight RJW, Wessels WLF, Magnusson M, Papadopoulos T,
et al. Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New
Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk. Plast
Reconstr Surg. 2017;140(4):645-54.
15. Tokin CA, Wallace AM. Breast cancer presenting within or adjacent to the breast implant
capsule: a case series and clinical recommendations. Clin Breast Cancer. 2012;12(4):296-9.
16. Grubstein A, Cohen M, Steinmetz A, Cohen D. Clin Imaging. 2011;35(3):228-31.
17. Hillard C, Fowler JD, Barta R, Cunningham B. Silicone breast implant rupture: a review.
Gland Surg. 2017;6(2):163-8.
18. Di Napoli A. Achieving Reliable Diagnosis in Late Breast Implant Seromas: From Reactive
to Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2019;143(3S A Review of Breast
Implant-Associated Anaplastic Large Cell Lymphoma):15S-22S.
19. Lyapichev KA, Piña-Oviedo S, Medeiros LJ, Evans MG, Liu H, Miranda AR, et al. A proposal
for pathologic processing of breast implant capsules in patients with suspected breast
implant anaplastic large cell lymphoma. Mod Pathol. 2020;33(3):367-79.
20. Ali SMH, Kathia UM, Gondal MUM, Zil-E-Ali A, Khan H, Riaz S. Impact of Clinical Information
on the Turnaround Time in Surgical Histopathology: A Retrospective Study. Cureus.
2018;10(5):e2596.
1. Rede D’Or São Luiz S.A., Departamento de Patologia, São Paulo, SP, Brazil
Corresponding author: Jaime Anger Av. Brigadeiro Luiz Antônio, 3889, São Paulo, SP, Brazil. Zip code: 01401-001, E-mail: anger@uol.com.br
Article received: November 3, 2021.
Article accepted: April 7, 2022.
Conflicts of interest: none.